Works matching IS 00302414 AND DT 2022 AND VI 100 AND IP 9
Results: 7
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 505, doi. 10.1159/000521086
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 1, doi. 10.1159/000526879
- Publication type:
- Article
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 512, doi. 10.1159/000525962
- By:
- Publication type:
- Article
Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 498, doi. 10.1159/000525928
- By:
- Publication type:
- Article
High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 485, doi. 10.1159/000525743
- By:
- Publication type:
- Article
Formin-Like 2 Is a Potential Biomarker of Poor Prognosis in Nasopharyngeal Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 475, doi. 10.1159/000525682
- By:
- Publication type:
- Article
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 467, doi. 10.1159/000525188
- By:
- Publication type:
- Article